05:54 PM EDT, 06/05/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on June 04, 2024, sold 28,000 shares in Avidity Biosciences ( RNA ) for $767,780. Following the Form 4 filing with the SEC, Boyce has control over a total of 112,117 shares of the company, with 112,117 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1599901/000159990124000077/xslF345X03/wk-form4_1717623967.xml
Price: 27.70, Change: -0.24, Percent Change: -0.86